awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47848286-F17290B1-00DA-4BE0-A712-65D086B20C45
Q47848286-F17290B1-00DA-4BE0-A712-65D086B20C45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47848286-F17290B1-00DA-4BE0-A712-65D086B20C45
Biologic Agents for the Treatment of Hypereosinophilic Syndromes.
P2860
Q47848286-F17290B1-00DA-4BE0-A712-65D086B20C45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47848286-F17290B1-00DA-4BE0-A712-65D086B20C45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d173e79651f541d8e822694d053cf9cc9af72c99
P2860
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.